Equifax (EFX) Earnings Growth Rebounds 17.1% Year-Over-Year, Upending Bearish Narratives
Equifax (EFX) delivered a notable turnaround this earnings season, with EPS climbing 17.1% year-over-year after recording a five-year average annual decline of 1.2%. Net profit margins also ticked upward to 11.1%, up from 10.1% a year earlier, underscoring an improvement in profitability. Looking ahead, the market is eyeing robust growth drivers as forecasts call for annual EPS growth of 20.24% over the next three years, which would outpace expectations for the broader US market.
See our full analysis for Equifax.Now, let’s see how these headline numbers stack up against the popular narratives. Some may echo the data, but others could be shaken up.
See what the community is saying about Equifax
Profit Margins Projected to Expand by Five Points
- Analysts expect Equifax’s profit margins to rise from 11.0% today to 16.8% over the next three years, a gain of nearly six percentage points.
- According to the analysts' consensus narrative, new product solutions and completed cloud migration are the main levers behind this expansion,
- The consensus narrative notes that structural changes, such as adoption of EFX.AI and government verification requirements, are increasing demand for Equifax’s services. This is expected to sustain revenue growth and margin improvement.
- In addition, technology investments and international expansions are making operations more scalable. This supports the high margin outlook even as industry competition intensifies.
See how analysts connect the dots between new products, margin growth, and long-term earnings potential in the consensus narrative. 📊 Read the full Equifax Consensus Narrative.
Legal and Regulatory Costs Unlikely to Ease Soon
- Equifax faces elevated legal expenses and heightened regulatory pressures, which are expected to remain a drag on net margins and increase expense volatility in upcoming periods.
- The analysts' consensus narrative highlights persistent litigation costs and consumer lawsuits as a key risk,
- Ongoing regulatory scrutiny on data privacy and fallout from past data breaches may keep compliance costs high and cut into future profit growth.
- These risks present a headwind even as Equifax pushes for improved margin performance from its core business.
Valuation Gap Grows Versus DCF but Trades at Industry Premium
- Equifax’s current share price of $229.93 is well below its DCF fair value estimate of $364.59, yet it trades at a price-to-earnings ratio of 43.2x, significantly higher than the professional services industry average of 26.1x.
- The analysts’ consensus narrative draws out the tension here,
- While growing profits and expanding margins may justify a premium, the current PE is notably elevated even versus peer levels (35.3x). This suggests investors are paying up for perceived durability and growth potential.
- The 10.2% gap between the current share price and the consensus price target of $275.25 points to more limited near-term upside unless growth accelerates beyond expectations or valuations ease in the sector.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Equifax on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Have a different take on the data? Share your perspective and craft your unique narrative in just a few minutes. Do it your way.
A great starting point for your Equifax research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
See What Else Is Out There
Despite improving profitability, Equifax’s elevated valuation and persistent legal and regulatory costs create uncertainty around sustaining premium returns for investors.
If you’re searching for better value and less pricing risk, target opportunities among these 877 undervalued stocks based on cash flows which may offer a more compelling reward for your capital right now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Equifax might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com